Vaginal Microbiome Testing Goes Consumer, Outpacing Clinical Evidence

Vaginal Microbiome Testing Goes Consumer, Outpacing Clinical Evidence

At-home vaginal microbiome tests from Evvy, Tiny Health, Viome, and ZOE use CLIA-certified sequencing to analyze bacterial and fungal composition, priced $199–$600. While clinical research links microbiome composition to preterm birth risk, the actionability of frequent testing in healthy individuals remains scientifically unproven. Consumer testing platforms now offer laboratory-grade analysis faster than clinical guidance exists for interpreting results and recommending interventions.

Published

Read at another depth